Diagnósticos da América S.A. (BVMF: DASA3)

Diagnósticos da América Statistics

Total Valuation

Diagnósticos da América has a market cap or net worth of BRL 2.25 billion. The enterprise value is 13.32 billion.

Market Cap	2.25B
Enterprise Value	13.32B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Diagnósticos da América has 747.42 million shares outstanding. The number of shares has increased by 14.35% in one year.

Shares Outstanding	747.42M
Shares Change (YoY)	+14.35%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	9.96%
Owned by Institutions (%)	80.14%
Float	672.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.15
PB Ratio	0.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.68, with an EV/FCF ratio of -13.04.

EV / Earnings	-13.34
EV / Sales	0.90
EV / EBITDA	6.68
EV / EBIT	13.71
EV / FCF	-13.04

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 195.68.

Current Ratio	1.63
Quick Ratio	1.54
Debt / Equity	195.68
Debt / EBITDA	7.04
Debt / FCF	-13.74
Interest Coverage	0.57

Financial Efficiency

Return on equity (ROE) is -12.46% and return on invested capital (ROIC) is 2.83%.

Return on Equity (ROE)	-12.46%
Return on Assets (ROA)	2.19%
Return on Capital (ROIC)	2.83%
Revenue Per Employee	814,183
Profits Per Employee	-55,035
Employee Count	18,142
Asset Turnover	0.53
Inventory Turnover	22.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.81% in the last 52 weeks. The beta is 0.36, so Diagnósticos da América's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-74.81%
50-Day Moving Average	3.14
200-Day Moving Average	5.63
Relative Strength Index (RSI)	45.69
Average Volume (20 Days)	992,775

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnósticos da América had revenue of BRL 14.77 billion and -998.44 million in losses. Loss per share was -1.34.

Revenue	14.77B
Gross Profit	3.96B
Operating Income	970.95M
Pretax Income	-824.48M
Net Income	-998.44M
EBITDA	1.61B
EBIT	970.95M
Loss Per Share	-1.34

Balance Sheet

The company has 2.99 billion in cash and 14.03 billion in debt, giving a net cash position of -11.05 billion or -14.78 per share.

Cash & Cash Equivalents	2.99B
Total Debt	14.03B
Net Cash	-11.05B
Net Cash Per Share	-14.78
Equity (Book Value)	7.17B
Book Value Per Share	9.57
Working Capital	3.55B

Cash Flow

In the last 12 months, operating cash flow was -574.92 million and capital expenditures -446.12 million, giving a free cash flow of -1.02 billion.

Operating Cash Flow	-574.92M
Capital Expenditures	-446.12M
Free Cash Flow	-1.02B
FCF Per Share	-1.37

Margins

Gross margin is 26.79%, with operating and profit margins of 6.57% and -6.76%.

Gross Margin	26.79%
Operating Margin	6.57%
Pretax Margin	-5.58%
Profit Margin	-6.76%
EBITDA Margin	10.87%
EBIT Margin	6.57%
FCF Margin	-6.91%

Dividends & Yields

Diagnósticos da América does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.35%
Shareholder Yield	-14.35%
Earnings Yield	-44.39%
FCF Yield	-45.38%

Stock Splits

The last stock split was on February 2, 2010. It was a forward split with a ratio of 4.

Last Split Date	Feb 2, 2010
Split Type	Forward
Split Ratio	4